Our Products
Our Products
At ABC International, we are dedicated to developing, manufacturing, sourcing and delivering only the highest quality pharmaceutical products along with renowned partners across the globe. Our unwavering mission is to bridge the gaps in the markets we serve in, with a primary focus on Myanmar.
We understand that in healthcare, excellence is non-negotiable. That’s why we have established partnerships with industry leaders who share our commitment to uncompromising quality and patient well-being. Our meticulously curated range of pharmaceutical and OTC products encompasses a wide spectrum of categories, ensuring that we cater to the diverse medical needs of our patients.
Whether it’s ground-breaking OTC products, cutting-edge medical devices, or critical healthcare essentials, we scour the world to bring the very best. Our tireless dedication to product quality ensures access to the Novel & effective quality pharmaceuticals.
At ABC International, we not only provide medications, we deliver a promise of quality, efficacy and safety.
Our Products
At ABC International, we are dedicated to developing, manufacturing, sourcing and delivering only the highest quality pharmaceutical products along with renowned partners across the globe. Our unwavering mission is to bridge the gaps in the markets we serve in, with a primary focus on Myanmar.
We understand that in healthcare, excellence is non-negotiable. That’s why we have established partnerships with industry leaders who share our commitment to uncompromising quality and patient well-being. Our meticulously curated range of pharmaceutical and OTC products encompasses a wide spectrum of categories, ensuring that we cater to the diverse medical needs of our patients.
Whether it’s ground-breaking OTC products, cutting-edge medical devices, or critical healthcare essentials, we scour the world to bring the very best. Our tireless dedication to product quality ensures access to the Novel & effective quality pharmaceuticals.
At ABC International, we not only provide medications, we deliver a promise of quality, efficacy and safety.
Quality Healthcare Products For Every Need
ABC International works with global majors to bridge the therapy gaps in Myanmar by providing quality pharmaceuticals.
Novapressin
Novapressin
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Novapressin
Novapressin
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Xavor 50 mg Tab
Xavor
Each film coated tablet contains:
Losartan potassium 50mg & Hydrochlorothiazide 12.5mg; Inactive Ingredients: Colloidal Anhydrous Silica; Magnesium Stearate; Sodium Starch Glycolate; Talcum; Microcrystalline Cellulose; Opadry Orange 85G53561; Carnauba Wax.
Uses
XAVOR-DIU is indicated for the treatment of hypertension.
XAVOR-DIU is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
Side Effect
Edema, Palpitation, Dizziness, Abdominal pain, Back pain, cough, sinusitis
Bilirubin increased (serum), BUN increased, hematocrit decreased, hemoglobin decreased, hyper-/hypotension hyponatremia, liver enzymes increased, rhabdomyolysis, serum creatinine increased, thrombocytopenia.
Xavor DIU Tab
Xavor
Each film coated tablet contains:
Losartan potassium 50mg & Hydrochlorothiazide 12.5mg; Inactive Ingredients: Colloidal Anhydrous Silica; Magnesium Stearate; Sodium Starch Glycolate; Talcum; Microcrystalline Cellulose; Opadry Orange 85G53561; Carnauba Wax.
Uses
XAVOR-DIU is indicated for the treatment of hypertension.
XAVOR-DIU is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
Side Effect
Edema, Palpitation, Dizziness, Abdominal pain, Back pain, cough, sinusitis
Bilirubin increased (serum), BUN increased, hematocrit decreased, hemoglobin decreased, hyper-/hypotension hyponatremia, liver enzymes increased, rhabdomyolysis, serum creatinine increased, thrombocytopenia.
Aurora 5 mg Tab
Aurora
Each film coated tablet contains:
Rosuvastatin 5mg, 10mg as Rosuvastatin calcium.
Uses
Aurora tablets are indicated:
- Primary hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
- As an adjunct to diet for the treatment of patients with elevated serum TG levels (Fredrickson type IV).
- Homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
Side Effect
The most frequent adverse events thought to be related to Rosuvastatin are:
- Myalgia,
- Constipation,
- Asthenia,
- Abdominal pain
- Nausea.
Body As a whole: Abdominal pain, accidental injury, chest pain, infection pain, pelvic pain and neck pain.
Cardiovascular System
Hypertension, angina pectoris, vasodilatation and palpitation.
Digestive System
Constipation, gastroenteritis, vomiting, flatulence, periodontal abscess and gastritis.
Endocrine: Diabetes mellitus.
Heroic and Lymphatic System: Anemia and ecchymosis.
Metabolic and Nutritional Disorders: Peripheral edema.
Musculoskeletal System: Arthritis, arthralgia, and pathological fracture. Nervous System
Dizziness, Insomnia, Hypertonia, Paresthesia, Depression, Anxiety, Vertigo and Neuralgia.
Respiratory System
Bronchitis, Cough increased, Dyspnea, Pneumonia, and Asthma.
Skin and Appendages
Rash and Pruritus.
Skin and Appendages: Rash and Pruritus.
Aurora 10 mg Tab
Aurora
Each film coated tablet contains:
Rosuvastatin 5mg, 10mg as Rosuvastatin calcium.
Uses
Aurora tablets are indicated:
- Primary hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
- As an adjunct to diet for the treatment of patients with elevated serum TG levels (Fredrickson type IV).
- Homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
Side Effect
The most frequent adverse events thought to be related to Rosuvastatin are:
- Myalgia,
- Constipation,
- Asthenia,
- Abdominal pain
- Nausea.
Body As a whole: Abdominal pain, accidental injury, chest pain, infection pain, pelvic pain and neck pain.
Cardiovascular System
Hypertension, angina pectoris, vasodilatation and palpitation.
Digestive System
Constipation, gastroenteritis, vomiting, flatulence, periodontal abscess and gastritis.
Endocrine: Diabetes mellitus.
Heroic and Lymphatic System: Anemia and ecchymosis.
Metabolic and Nutritional Disorders: Peripheral edema.
Musculoskeletal System: Arthritis, arthralgia, and pathological fracture. Nervous System
Dizziness, Insomnia, Hypertonia, Paresthesia, Depression, Anxiety, Vertigo and Neuralgia.
Respiratory System
Bronchitis, Cough increased, Dyspnea, Pneumonia, and Asthma.
Skin and Appendages
Rash and Pruritus.
Skin and Appendages: Rash and Pruritus.
Carveda 6.25 mg Tab
Carveda
Composition
Each tablet contains carvedilol 6.25 mg
Uses
Hypertension
Heart failure
Left ventricular dysfunction following myocardial infarction
Side Effect
Heart failure and left ventricular dysfunction following myocardial infarction (>10%): Dizziness, fatigue, hypotension, diarrhea, hyperglycemia, bradycardia, weight increase. Hypertension(>5%): Dizziness.
Xavor 50 mg Tab
Xavor
Each film coated tablet contains:
Losartan potassium 50mg & Hydrochlorothiazide 12.5mg; Inactive Ingredients: Colloidal Anhydrous Silica; Magnesium Stearate; Sodium Starch Glycolate; Talcum; Microcrystalline Cellulose; Opadry Orange 85G53561; Carnauba Wax.
Uses
XAVOR-DIU is indicated for the treatment of hypertension.
XAVOR-DIU is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
Side Effect
Edema, Palpitation, Dizziness, Abdominal pain, Back pain, cough, sinusitis
Bilirubin increased (serum), BUN increased, hematocrit decreased, hemoglobin decreased, hyper-/hypotension hyponatremia, liver enzymes increased, rhabdomyolysis, serum creatinine increased, thrombocytopenia.
Xavor DIU Tab
Xavor
Each film coated tablet contains:
Losartan potassium 50mg & Hydrochlorothiazide 12.5mg; Inactive Ingredients: Colloidal Anhydrous Silica; Magnesium Stearate; Sodium Starch Glycolate; Talcum; Microcrystalline Cellulose; Opadry Orange 85G53561; Carnauba Wax.
Uses
XAVOR-DIU is indicated for the treatment of hypertension.
XAVOR-DIU is indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.
Side Effect
Edema, Palpitation, Dizziness, Abdominal pain, Back pain, cough, sinusitis
Bilirubin increased (serum), BUN increased, hematocrit decreased, hemoglobin decreased, hyper-/hypotension hyponatremia, liver enzymes increased, rhabdomyolysis, serum creatinine increased, thrombocytopenia.
Aurora 5 mg Tab
Aurora
Each film coated tablet contains:
Rosuvastatin 5mg, 10mg as Rosuvastatin calcium.
Uses
Aurora tablets are indicated:
- Primary hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
- As an adjunct to diet for the treatment of patients with elevated serum TG levels (Fredrickson type IV).
- Homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
Side Effect
The most frequent adverse events thought to be related to Rosuvastatin are:
- Myalgia,
- Constipation,
- Asthenia,
- Abdominal pain
- Nausea.
Body As a whole: Abdominal pain, accidental injury, chest pain, infection pain, pelvic pain and neck pain.
Cardiovascular System
Hypertension, angina pectoris, vasodilatation and palpitation.
Digestive System
Constipation, gastroenteritis, vomiting, flatulence, periodontal abscess and gastritis.
Endocrine: Diabetes mellitus.
Heroic and Lymphatic System: Anemia and ecchymosis.
Metabolic and Nutritional Disorders: Peripheral edema.
Musculoskeletal System: Arthritis, arthralgia, and pathological fracture. Nervous System
Dizziness, Insomnia, Hypertonia, Paresthesia, Depression, Anxiety, Vertigo and Neuralgia.
Respiratory System
Bronchitis, Cough increased, Dyspnea, Pneumonia, and Asthma.
Skin and Appendages
Rash and Pruritus.
Skin and Appendages: Rash and Pruritus.
Aurora 10 mg Tab
Aurora
Each film coated tablet contains:
Rosuvastatin 5mg, 10mg as Rosuvastatin calcium.
Uses
Aurora tablets are indicated:
- Primary hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate.
- As an adjunct to diet for the treatment of patients with elevated serum TG levels (Fredrickson type IV).
- Homozygous familial hypercholesterolemia as an adjunct to diet and other lipid lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.
Side Effect
The most frequent adverse events thought to be related to Rosuvastatin are:
- Myalgia,
- Constipation,
- Asthenia,
- Abdominal pain
- Nausea.
Body As a whole: Abdominal pain, accidental injury, chest pain, infection pain, pelvic pain and neck pain.
Cardiovascular System
Hypertension, angina pectoris, vasodilatation and palpitation.
Digestive System
Constipation, gastroenteritis, vomiting, flatulence, periodontal abscess and gastritis.
Endocrine: Diabetes mellitus.
Heroic and Lymphatic System: Anemia and ecchymosis.
Metabolic and Nutritional Disorders: Peripheral edema.
Musculoskeletal System: Arthritis, arthralgia, and pathological fracture. Nervous System
Dizziness, Insomnia, Hypertonia, Paresthesia, Depression, Anxiety, Vertigo and Neuralgia.
Respiratory System
Bronchitis, Cough increased, Dyspnea, Pneumonia, and Asthma.
Skin and Appendages
Rash and Pruritus.
Skin and Appendages: Rash and Pruritus.
Carveda 6.25 mg Tab
Carveda
Composition
Each tablet contains carvedilol 6.25 mg
Uses
Hypertension
Heart failure
Left ventricular dysfunction following myocardial infarction
Side Effect
Heart failure and left ventricular dysfunction following myocardial infarction (>10%): Dizziness, fatigue, hypotension, diarrhea, hyperglycemia, bradycardia, weight increase. Hypertension(>5%): Dizziness.
T4 50 mcg Tab
T4 50 mcg/ 100 mcg Tab
Each multi-scored tablet contains
LEVOTHYROXINE SODIUM 50 mcg/ 100 mcg
Inactive Ingredients:
Lactose, Microcrystalline Cellulose, Cellulose powder, Croscaramellose sodium, Magnesium Stearate, Quinoline yellow ( aluminium lake)
Uses
- As replacement or supplement therapy in patients with hypothyroidism of any aetiology (except transient hypothyroidism during the recovery phase of sub-acute thyroiditis): primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goitre; secondary (pituitary)
- hypothyroidism; and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
- For the suppression of pituitary Thyrotropin (TSH) in the treatment or prevention of various types of euthyroid goitres, including thyroid nodules, sub-acute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis), multinodular goitre and as an adjunct to surgery and radiolabelled iodine therapy in the management of TSH-dependent thyroid papillary carcinoma or well differentiated follicular carcinoma.
Side Effect
Adverse reactions different from those indicative of thyrotoxicosis as a result of therapeutic overdosage (either initially or during maintenance) are rare.In infants receiving hormone replacement therapy acraniosynostosis has been associated to latrogenic hyperthyroidism.
Inadequate dosage of the product may fail to resolve hypothyroidism symptoms.
There may be hypersensitivity reactions, such as rash and urticaria, to inactive ingredients in the product.
There may be partial hair loss during the early months of therapy, although this is generally transient.
Benign intracranial hypertension has been reported in children receiving levothyroxine therapy.
T4 100 mcg Tab
T4 50 mcg/ 100 mcg Tab
Each multi-scored tablet contains
LEVOTHYROXINE SODIUM 50 mcg/ 100 mcg
Inactive Ingredients:
Lactose, Microcrystalline Cellulose, Cellulose powder, Croscaramellose sodium, Magnesium Stearate, Quinoline yellow ( aluminium lake)
Uses
- As replacement or supplement therapy in patients with hypothyroidism of any aetiology (except transient hypothyroidism during the recovery phase of sub-acute thyroiditis): primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goitre; secondary (pituitary)
- hypothyroidism; and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
- For the suppression of pituitary Thyrotropin (TSH) in the treatment or prevention of various types of euthyroid goitres, including thyroid nodules, sub-acute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis), multinodular goitre and as an adjunct to surgery and radiolabelled iodine therapy in the management of TSH-dependent thyroid papillary carcinoma or well differentiated follicular carcinoma.
Side Effect
Adverse reactions different from those indicative of thyrotoxicosis as a result of therapeutic overdosage (either initially or during maintenance) are rare.In infants receiving hormone replacement therapy acraniosynostosis has been associated to latrogenic hyperthyroidism.
Inadequate dosage of the product may fail to resolve hypothyroidism symptoms.
There may be hypersensitivity reactions, such as rash and urticaria, to inactive ingredients in the product.
There may be partial hair loss during the early months of therapy, although this is generally transient.
Benign intracranial hypertension has been reported in children receiving levothyroxine therapy.
T4 50 mcg Tab
T4 50 mcg/ 100 mcg Tab
Each multi-scored tablet contains
LEVOTHYROXINE SODIUM 50 mcg/ 100 mcg
Inactive Ingredients:
Lactose, Microcrystalline Cellulose, Cellulose powder, Croscaramellose sodium, Magnesium Stearate, Quinoline yellow ( aluminium lake)
Uses
- As replacement or supplement therapy in patients with hypothyroidism of any aetiology (except transient hypothyroidism during the recovery phase of sub-acute thyroiditis): primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goitre; secondary (pituitary)
- hypothyroidism; and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
- For the suppression of pituitary Thyrotropin (TSH) in the treatment or prevention of various types of euthyroid goitres, including thyroid nodules, sub-acute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis), multinodular goitre and as an adjunct to surgery and radiolabelled iodine therapy in the management of TSH-dependent thyroid papillary carcinoma or well differentiated follicular carcinoma.
Side Effect
Adverse reactions different from those indicative of thyrotoxicosis as a result of therapeutic overdosage (either initially or during maintenance) are rare.In infants receiving hormone replacement therapy acraniosynostosis has been associated to latrogenic hyperthyroidism.
Inadequate dosage of the product may fail to resolve hypothyroidism symptoms.
There may be hypersensitivity reactions, such as rash and urticaria, to inactive ingredients in the product.
There may be partial hair loss during the early months of therapy, although this is generally transient.
Benign intracranial hypertension has been reported in children receiving levothyroxine therapy.
T4 100 mcg Tab
T4 50 mcg/ 100 mcg Tab
Each multi-scored tablet contains
LEVOTHYROXINE SODIUM 50 mcg/ 100 mcg
Inactive Ingredients:
Lactose, Microcrystalline Cellulose, Cellulose powder, Croscaramellose sodium, Magnesium Stearate, Quinoline yellow ( aluminium lake)
Uses
- As replacement or supplement therapy in patients with hypothyroidism of any aetiology (except transient hypothyroidism during the recovery phase of sub-acute thyroiditis): primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total congenital absence of the thyroid gland, or from the effects of surgery, radiation or drugs, with or without the presence of goitre; secondary (pituitary)
- hypothyroidism; and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.
- For the suppression of pituitary Thyrotropin (TSH) in the treatment or prevention of various types of euthyroid goitres, including thyroid nodules, sub-acute or chronic lymphocytic thyroiditis (Hashimoto’s thyroiditis), multinodular goitre and as an adjunct to surgery and radiolabelled iodine therapy in the management of TSH-dependent thyroid papillary carcinoma or well differentiated follicular carcinoma.
Side Effect
Adverse reactions different from those indicative of thyrotoxicosis as a result of therapeutic overdosage (either initially or during maintenance) are rare.In infants receiving hormone replacement therapy acraniosynostosis has been associated to latrogenic hyperthyroidism.
Inadequate dosage of the product may fail to resolve hypothyroidism symptoms.
There may be hypersensitivity reactions, such as rash and urticaria, to inactive ingredients in the product.
There may be partial hair loss during the early months of therapy, although this is generally transient.
Benign intracranial hypertension has been reported in children receiving levothyroxine therapy.
Carbomark 450 mg Inj
Carbomark
Composition
Carboplatin 150/450mg
Uses
Carboplatin is used to treat a number of Cancers which include ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma, testicular cancer and triple-negative breast cancer.
Side Effect
Common side effects of carboplatin include:
nausea, vomiting, numbness and tingling of extremities, ear infection, pain, weakness, allergic reactions, and hair loss.
Serious side effects of carboplatin include: bleeding and reduced blood cells, including reduced red blood cells (anemia) and platelets (needed for proper blood clotting);
unusual bruising or bleeding, black tarry stools or blood in the urine;
infection;
life-threatening allergic reaction;
kidney and liver problems; or
loss of hearing or ringing in the ears.
Carbomark 150 mg In
Carbomark
Composition
Carboplatin 150/450mg
Uses
Carboplatin is used to treat a number of Cancers which include ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma, testicular cancer and triple-negative breast cancer.
Side Effect
Common side effects of carboplatin include:
nausea, vomiting, numbness and tingling of extremities, ear infection, pain, weakness, allergic reactions, and hair loss.
Serious side effects of carboplatin include: bleeding and reduced blood cells, including reduced red blood cells (anemia) and platelets (needed for proper blood clotting);
unusual bruising or bleeding, black tarry stools or blood in the urine;
infection;
life-threatening allergic reaction;
kidney and liver problems; or
loss of hearing or ringing in the ears.
Cismark 50 mg Inj
Cismark
Composition
Cisplatin 50mg
Uses
Cisplatin is used for the treatment of advanced ovarian cancer, testicular cancer, and bladder carcinoma
Side Effect
Nausea, Vomiting, Diarrhea, Temporary hair loss, Loss in ability to taste food, Hiccups, Dry mouth, Dark urine, Decreased sweating, Dry skin , Signs of dehydration, Rash, Itching, Blurred vision, Dizziness, Drowsiness, Headache, Allergic reactions, Blisters, Redness of skin, Peeling of the skin, Restlessness, Lightheadedness, Feeling exhausted too early, Stomach pain, Abdominal pain, Body pain, Swollen legs, Face swelling, Swollen throat, Numbness, Reduce in the number of white blood cells, Bruising and leeding, Anaemia (low number of red blood cells), Feeling sick, Loss of appetite, hearing loss.
Doxomark 10 mg Inj
Doxomark
Composition
Doxorubicin 10/50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Doxomark 50 mg Inj
Doxomark
Composition
Doxorubicin 10/50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Gemcel 1000 mg Inj
Gemcel
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopathy
Gemcel 200 mg Inj
Gemcel
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopathy
Oxamark 50 mg Inj
Oxamark
Composition
Oxaliplatin 50/100mg
Uses
For management of Colorectal Cancers
Side Effect
Peripheral neuropathy (76%), Anemia (64%), Nausea (64%), Fatigue (61%), Diarrhea (46%), Vomiting (37%), Abdominal pain (31%), Constipation(31%), Thrombocytopenia (30%), Fever (25%), Anorexia (20%), Leukopenia (13%), Dyspnea (13%), Cough (11%), 1-10%, Edema (10%), Neutropenia (7%), Pharyngolaryngeal dysesthesia (1-2%), <1%, Pulmonary fibrosis, Posterior leukoencephalopathy syndrome.
pathy
Oxamark 100 mg Inj
Oxamark
Composition
Oxaliplatin 50/100mg
Uses
For management of Colorectal Cancers
Side Effect
Peripheral neuropathy (76%), Anemia (64%), Nausea (64%), Fatigue (61%), Diarrhea (46%), Vomiting (37%), Abdominal pain (31%), Constipation(31%), Thrombocytopenia (30%), Fever (25%), Anorexia (20%), Leukopenia (13%), Dyspnea (13%), Cough (11%), 1-10%, Edema (10%), Neutropenia (7%), Pharyngolaryngeal dysesthesia (1-2%), <1%, Pulmonary fibrosis, Posterior leukoencephalopathy syndrome.
pathy
Paclimark 30 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Paclimark 100 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Paclimark 260 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Donataxel 20 mg Inj
Donataxel
Composition
Docetaxel 20/80mg
Uses
Breast Cancer, Prostate cancer, Non-Small cell Lung cancer
Side Effect
>50% Alopecia, Anemia, Leukopenia, Neutropenia, Asthenia, 10-50%, Fever, Infections, Fluid retention, Hypersensitivity, Skin reactions, Diarrhea, Nausea, Vomiting, Sensory neuropathy, Myalgia, Nail changes, 1-10%, Arthralgia, Thrombocytopenia.
Donataxel 80 mg Inj
Donataxel
Composition
Docetaxel 20/80mg
Uses
Breast Cancer, Prostate cancer, Non-Small cell Lung cancer
Side Effect
>50% Alopecia, Anemia, Leukopenia, Neutropenia, Asthenia, 10-50%, Fever, Infections, Fluid retention, Hypersensitivity, Skin reactions, Diarrhea, Nausea, Vomiting, Sensory neuropathy, Myalgia, Nail changes, 1-10%, Arthralgia, Thrombocytopenia.
Doxite 50 mcg Inj
Doxtie
Composition
Doxorubicin 50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Gembio 200 mg Inj
Gembio
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopat
Gembio 1 gm Inj
Gembio
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopat
Oncofusion IV Infusion Set
Oncofusion
Uses
PVC free IV set for administration of drugs which can react with PVC in normal IV sets (eg: Paclitaxel, Docetaxel etc)
Tzmide 20 mg Inj
TZmide Capsule
Composition
Temozopamide 20/100mg. Capsule
Uses
Astrocytoma, Glioblastoma Multiforme
Side Effect
Alopecia (55-69%), Lymphopenia (55%), Nausea (53%), Vomiting (42%), Headache (41%), Fatigue (34%), Constipation (33%), Anorexia (9-27%), Convulsions (23%), Thrombocytopenia (19%), Rash (8-19%), Hemiparesis (18%), Diarrhea (16%), Neutropenia (14%), Fever (13%), Asthenia (13%), Dizziness (12%), Peripheral edema (11%), Viral infections (11%), 1-10% (selected), Amnesia (10%), Insomnia (10%), Abdominal pain (5-9%), Ataxia (8%), Back pain (8%), Paresis (8%), URI (8%), Urinary incontinence (8%), UTI (8%), Abnormal vision (5-8%), Pruritus (5-8%), Breast pain (6%), Depression (6%), Confusion (5%), Myalgia (5%), Weight gain (5%), Anemia (4%), Erythema (1%).
Tzmide 100 mg Inj
TZmide Capsule
Composition
Temozopamide 20/100mg. Capsule
Uses
Astrocytoma, Glioblastoma Multiforme
Side Effect
Alopecia (55-69%), Lymphopenia (55%), Nausea (53%), Vomiting (42%), Headache (41%), Fatigue (34%), Constipation (33%), Anorexia (9-27%), Convulsions (23%), Thrombocytopenia (19%), Rash (8-19%), Hemiparesis (18%), Diarrhea (16%), Neutropenia (14%), Fever (13%), Asthenia (13%), Dizziness (12%), Peripheral edema (11%), Viral infections (11%), 1-10% (selected), Amnesia (10%), Insomnia (10%), Abdominal pain (5-9%), Ataxia (8%), Back pain (8%), Paresis (8%), URI (8%), Urinary incontinence (8%), UTI (8%), Abnormal vision (5-8%), Pruritus (5-8%), Breast pain (6%), Depression (6%), Confusion (5%), Myalgia (5%), Weight gain (5%), Anemia (4%), Erythema (1%).
Bortemark 3.5 mg Inj
Bortemark
Composition
Bortezomib 3.5mg
Uses
Mantle cell Lymphoma, Multiple myeloma
Side Effect
Asthenia (61-65%), Nausea (61-65%), Diarrhea (51-55%), Anorexia (41-45%), Constipation (41-45%), Thrombocytopenia (41-45%), Peripheral neuropathy (IV: 16-41%; SC: 6-24%), Pyrexia (36-40%), Vomiting (36-40%), Anemia (31-35%), Arthralgia (26-30%), Headache (26-30%), Insomnia (26-30%), Limb pain (26-30%), Dizziness (21-25%), Dyspnea (21-25%), Edema (21-25%), Neutropenia (21-25%), Paresthesia (21-25%), Rash (21-25%), Cough (15-20%), Dehydration (15-20%), URI (15-20%), Rigors, grade 4 toxicity (10-15%), Frequency Not Defined, Hypotension, Anxiety, Pain, Pruritus, Abdominal pain, Dyspepsia, Back pain, Bone pain, Myalgia, Muscle spasms, Herpes zoster, Pneumonia, Blurred vision.
Photofusion IV Infusion Set
Photofusion
Uses
For administration of Photosensitive (light sensitive) drugs
Idelara 2.5 mg
IDelara
Composition
Letrozole 2.5mg tablets
Uses
Breast Cancer in Postmenopausal women, Hornone receptor Positive Breast Cancer
Side Effect
Diaphoresis (24%), Bone pain (22%), Hot flashes (19%), Back pain (18%), Dyspnea (18%), Nausea (17%), Night sweats (14%), Cough (13%), Fatigue (13%), 1-10%, Constipation (10%), Hypertension (8%), Chest pain (8%), Diarrhea (8%), Decr wt (7%), Edema (7%), Breast pain (7%), Bone fractures (6%), UTI (6%), Hypercalcemia (5%), Headache (4%), Weakness (4%), Vomiting (3%), Osteoporosis (2%).
Panataxel 30 mg
Panataxel
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Panataxel 100 mg
Panataxel
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Carbomark 450 mg Inj
Carbomark
Composition
Carboplatin 150/450mg
Uses
Carboplatin is used to treat a number of Cancers which include ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma, testicular cancer and triple-negative breast cancer.
Side Effect
Common side effects of carboplatin include:
nausea, vomiting, numbness and tingling of extremities, ear infection, pain, weakness, allergic reactions, and hair loss.
Serious side effects of carboplatin include: bleeding and reduced blood cells, including reduced red blood cells (anemia) and platelets (needed for proper blood clotting);
unusual bruising or bleeding, black tarry stools or blood in the urine;
infection;
life-threatening allergic reaction;
kidney and liver problems; or
loss of hearing or ringing in the ears.
Carbomark 150 mg In
Carbomark
Composition
Carboplatin 150/450mg
Uses
Carboplatin is used to treat a number of Cancers which include ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma, testicular cancer and triple-negative breast cancer.
Side Effect
Common side effects of carboplatin include:
nausea, vomiting, numbness and tingling of extremities, ear infection, pain, weakness, allergic reactions, and hair loss.
Serious side effects of carboplatin include: bleeding and reduced blood cells, including reduced red blood cells (anemia) and platelets (needed for proper blood clotting);
unusual bruising or bleeding, black tarry stools or blood in the urine;
infection;
life-threatening allergic reaction;
kidney and liver problems; or
loss of hearing or ringing in the ears.
Cismark 50 mg Inj
Cismark
Composition
Cisplatin 50mg
Uses
Cisplatin is used for the treatment of advanced ovarian cancer, testicular cancer, and bladder carcinoma
Side Effect
Nausea, Vomiting, Diarrhea, Temporary hair loss, Loss in ability to taste food, Hiccups, Dry mouth, Dark urine, Decreased sweating, Dry skin , Signs of dehydration, Rash, Itching, Blurred vision, Dizziness, Drowsiness, Headache, Allergic reactions, Blisters, Redness of skin, Peeling of the skin, Restlessness, Lightheadedness, Feeling exhausted too early, Stomach pain, Abdominal pain, Body pain, Swollen legs, Face swelling, Swollen throat, Numbness, Reduce in the number of white blood cells, Bruising and leeding, Anaemia (low number of red blood cells), Feeling sick, Loss of appetite, hearing loss.
Doxomark 10 mg Inj
Doxomark
Composition
Doxorubicin 10/50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Doxomark 50 mg Inj
Doxomark
Composition
Doxorubicin 10/50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Gemcel 1000 mg Inj
Gemcel
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopathy
Gemcel 200 mg Inj
Gemcel
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopathy
Oxamark 50 mg Inj
Oxamark
Composition
Oxaliplatin 50/100mg
Uses
For management of Colorectal Cancers
Side Effect
Peripheral neuropathy (76%), Anemia (64%), Nausea (64%), Fatigue (61%), Diarrhea (46%), Vomiting (37%), Abdominal pain (31%), Constipation(31%), Thrombocytopenia (30%), Fever (25%), Anorexia (20%), Leukopenia (13%), Dyspnea (13%), Cough (11%), 1-10%, Edema (10%), Neutropenia (7%), Pharyngolaryngeal dysesthesia (1-2%), <1%, Pulmonary fibrosis, Posterior leukoencephalopathy syndrome.
pathy
Oxamark 100 mg Inj
Oxamark
Composition
Oxaliplatin 50/100mg
Uses
For management of Colorectal Cancers
Side Effect
Peripheral neuropathy (76%), Anemia (64%), Nausea (64%), Fatigue (61%), Diarrhea (46%), Vomiting (37%), Abdominal pain (31%), Constipation(31%), Thrombocytopenia (30%), Fever (25%), Anorexia (20%), Leukopenia (13%), Dyspnea (13%), Cough (11%), 1-10%, Edema (10%), Neutropenia (7%), Pharyngolaryngeal dysesthesia (1-2%), <1%, Pulmonary fibrosis, Posterior leukoencephalopathy syndrome.
pathy
Paclimark 30 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Paclimark 100 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Paclimark 260 mg Inj
Paclimark
Composition
Paclitaxel 30/100/260mg
Novapressin contains
Uses
Breast cancer, Ovarian cancer, Non-Small cell Lung cancer, AIDS related Kaposi’s Sarcoma
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
Neutropenia (78-100%), Alopecia (55-96%), Anemia (47-96%), Arthralgia/myalgia (93%), Diarrhea (90%), Leukopenia (90%), Nausea/vomiting (9-88%), Opportunistic infections (76%), Peripheral neuropathy (42-79%), Thrombocytopenia (4-68%), Mucositis (5-45%), Hypersensitivity (2-45%), Renal impairment (34%), Hypotension (17%), 1-10%, Bradycardia (3%), <1%, Grand mal seizures, Cardiac conduction abnormalities.
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Donataxel 20 mg Inj
Donataxel
Composition
Docetaxel 20/80mg
Uses
Breast Cancer, Prostate cancer, Non-Small cell Lung cancer
Side Effect
>50% Alopecia, Anemia, Leukopenia, Neutropenia, Asthenia, 10-50%, Fever, Infections, Fluid retention, Hypersensitivity, Skin reactions, Diarrhea, Nausea, Vomiting, Sensory neuropathy, Myalgia, Nail changes, 1-10%, Arthralgia, Thrombocytopenia.
Donataxel 80 mg Inj
Donataxel
Composition
Docetaxel 20/80mg
Uses
Breast Cancer, Prostate cancer, Non-Small cell Lung cancer
Side Effect
>50% Alopecia, Anemia, Leukopenia, Neutropenia, Asthenia, 10-50%, Fever, Infections, Fluid retention, Hypersensitivity, Skin reactions, Diarrhea, Nausea, Vomiting, Sensory neuropathy, Myalgia, Nail changes, 1-10%, Arthralgia, Thrombocytopenia.
Doxite 50 mcg Inj
Doxtie
Composition
Doxorubicin 50mg
Uses
Doxorubicin is commonly used to treat some leukemias and Hodgkin’s lymphoma, as well as cancers of the bladder, breast, stomach, lung, ovaries, thyroid, soft tissue sarcoma, multiple myeloma.
Side Effect
Cough or hoarseness accompanied by fever or chills
darkening or redness of the skin (if you recently had radiation treatment)
fast or irregular heartbeat
fever or chills
joint pain
lower back or side pain accompanied by fever or chills
pain at the injection site
painful or difficult urination accompanied by fever or chills
red streaks along the injected vein
shortness of breath
stomach pain
swelling of the feet and lower legs
Rare
Black, tarry stools
blood in the urine
pinpoint red spots on the skin
unusual bleeding or bruising.
Gembio 200 mg Inj
Gembio
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopat
Gembio 1 gm Inj
Gembio
Composition
Gemcitabine 200mg/ 1gm
Uses
Pancreatic Cancer, Non-small Cell Lung Cancer,
Breast Cancer,
Ovarian Cancer
Side Effect
Anemia (65%), Elev LFTs (68%), Neutropenia (63%), Leukopenia (62%), Pain (48%), Proteinuria (45%), Fever (41%), Hematuria (35%), Rash (30%), Thrombocytopenia (24%), Dyspnea (23%), Constipation (23%), Diarrhea (19%), Flu-like syndrome (19%), Hemorrhage (17%), BUN increased (16%), Infection (16%), Alopecia (15%), Edema (13%), Elev bilirubin (13%), 1-10%, Paresthesia (2-10%), Creatinine increased (2-8%), Inj site reactions (4%), Bronchospasm (2%)
Postmarketing Reports
Cardiovascular: CHF, MI, arrhythmias, supraventricular arrhythmias
Vascular disorders: Peripheral vasculitis, gangrene, capillary leak syndrome
Skin: Cellulitis, pseudocellulitis, severe skin reactions, including desquamation and bullous skin eruptions
Hepatic: Hepatic failure, hepatic veno-occlusive disease
Pulmonary: Interstitial pneumonitis, pulmonary fibrosis, pulmonary edema, ARDS
Pulmonary: Pulmonary eosinophilia
Blood and lymphatic system: Thrombotic microangiopat
Oncofusion IV Infusion Set
Oncofusion
Uses
PVC free IV set for administration of drugs which can react with PVC in normal IV sets (eg: Paclitaxel, Docetaxel etc)
Tzmide 20 mg Inj
TZmide Capsule
Composition
Temozopamide 20/100mg. Capsule
Uses
Astrocytoma, Glioblastoma Multiforme
Side Effect
Alopecia (55-69%), Lymphopenia (55%), Nausea (53%), Vomiting (42%), Headache (41%), Fatigue (34%), Constipation (33%), Anorexia (9-27%), Convulsions (23%), Thrombocytopenia (19%), Rash (8-19%), Hemiparesis (18%), Diarrhea (16%), Neutropenia (14%), Fever (13%), Asthenia (13%), Dizziness (12%), Peripheral edema (11%), Viral infections (11%), 1-10% (selected), Amnesia (10%), Insomnia (10%), Abdominal pain (5-9%), Ataxia (8%), Back pain (8%), Paresis (8%), URI (8%), Urinary incontinence (8%), UTI (8%), Abnormal vision (5-8%), Pruritus (5-8%), Breast pain (6%), Depression (6%), Confusion (5%), Myalgia (5%), Weight gain (5%), Anemia (4%), Erythema (1%).
Tzmide 100 mg Inj
TZmide Capsule
Composition
Temozopamide 20/100mg. Capsule
Uses
Astrocytoma, Glioblastoma Multiforme
Side Effect
Alopecia (55-69%), Lymphopenia (55%), Nausea (53%), Vomiting (42%), Headache (41%), Fatigue (34%), Constipation (33%), Anorexia (9-27%), Convulsions (23%), Thrombocytopenia (19%), Rash (8-19%), Hemiparesis (18%), Diarrhea (16%), Neutropenia (14%), Fever (13%), Asthenia (13%), Dizziness (12%), Peripheral edema (11%), Viral infections (11%), 1-10% (selected), Amnesia (10%), Insomnia (10%), Abdominal pain (5-9%), Ataxia (8%), Back pain (8%), Paresis (8%), URI (8%), Urinary incontinence (8%), UTI (8%), Abnormal vision (5-8%), Pruritus (5-8%), Breast pain (6%), Depression (6%), Confusion (5%), Myalgia (5%), Weight gain (5%), Anemia (4%), Erythema (1%).
Bortemark 3.5 mg Inj
Bortemark
Composition
Bortezomib 3.5mg
Uses
Mantle cell Lymphoma, Multiple myeloma
Side Effect
Asthenia (61-65%), Nausea (61-65%), Diarrhea (51-55%), Anorexia (41-45%), Constipation (41-45%), Thrombocytopenia (41-45%), Peripheral neuropathy (IV: 16-41%; SC: 6-24%), Pyrexia (36-40%), Vomiting (36-40%), Anemia (31-35%), Arthralgia (26-30%), Headache (26-30%), Insomnia (26-30%), Limb pain (26-30%), Dizziness (21-25%), Dyspnea (21-25%), Edema (21-25%), Neutropenia (21-25%), Paresthesia (21-25%), Rash (21-25%), Cough (15-20%), Dehydration (15-20%), URI (15-20%), Rigors, grade 4 toxicity (10-15%), Frequency Not Defined, Hypotension, Anxiety, Pain, Pruritus, Abdominal pain, Dyspepsia, Back pain, Bone pain, Myalgia, Muscle spasms, Herpes zoster, Pneumonia, Blurred vision.
Photofusion IV Infusion Set
Photofusion
Uses
For administration of Photosensitive (light sensitive) drugs
Idelara 2.5 mg
IDelara
Composition
Letrozole 2.5mg tablets
Uses
Breast Cancer in Postmenopausal women, Hornone receptor Positive Breast Cancer
Side Effect
Diaphoresis (24%), Bone pain (22%), Hot flashes (19%), Back pain (18%), Dyspnea (18%), Nausea (17%), Night sweats (14%), Cough (13%), Fatigue (13%), 1-10%, Constipation (10%), Hypertension (8%), Chest pain (8%), Diarrhea (8%), Decr wt (7%), Edema (7%), Breast pain (7%), Bone fractures (6%), UTI (6%), Hypercalcemia (5%), Headache (4%), Weakness (4%), Vomiting (3%), Osteoporosis (2%).
Panataxel 30 mg
Panataxel
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Panataxel 100 mg
Panataxel
Novapressin contains
Terlipressin Acetate (triglycyl¬lysine-vasopressin) 1mg
Uses
Novapressin is indicated in the treatment of bleeding oesophageal varices and emergency treatment of type 1 hepatorenal syndrome,as defined by IAC (International Ascites Club) criteria.
Side Effect
paleness of face and body and a slight blood pressure increase, headache and, local necrosis, abdominal pain, nausea, diarrhoea and spontaneous evacuation. Dyspnea, hyponatraemia and hypokalaemia
Azeflumark Nasal Spray
Azeflumark Nasal Spray
Each Metered Spray Delivers:
Azelastine Hydrochloride BP 140 mcg
Fluticasone Propionate BP 50 mcg
Composition:
Azelastine Hydrochloride BP 0.14% w/v
Fluticasone Propionate BP 0.05% w/v
Preservatives: Benzalkonium Chloride Solution BP 0.02% w/v
Phenylethyl Alcohol USP 0.25% w/v
Excipients q.s
Uses
Azeflumark nasal spray is indicated for the management of symptoms of allergic rhinitis, once the need for an antihistamine and corticosteroid has
been established. It is recommended for the treatment of moderate to severe persistent symptoms in adults and adolescents above 12 years of age. It can be used for treating non- allergic vasomotor rhinitis in adults and adolescents, 12 years of age and older. For children aged 5-12 years, recommended for severe symptoms of allergic rhinitis.
Side Effect
The most likely side effects with the combination of azelastine hydrochloride and fluticasone propionate are headache, somnolence, pharyngitis, epistaxis, nasal burning/ irritation, nausea, vomiting, cough, and taste disturbances. The combination may produce a bitter taste which may lead to occasional nausea. This hitter taste usually disappears after sometime.
Metomark Nasal Spray
Metomark Nasal Spray
Each Metered Spray Delivers:
Mometasone Furoate Monohydrate
Equivalent to Mometasone Furoate USP 50 mcg
Composition:
Mometasone Furoate Monohydrate
Equivalent to Mometasone Furoate USP 0.05% w/v
Preservative
Benzalkonium Chloride Solution BP 0.02% w/v
Phenyl Ethyl Alcohol USP 0.25% w/v
Uses
Mometasone Furoate Nasal Spray is indicated for use in adults and children 12 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis.
Mometasone Furoate Nasal Spray is indicated for the treatment of nasal polyps in adults 18 years of age and older.
Mometasone Furoate Nasal Spray is also indicated or use in children 6 to 11 years of age to treat the symptoms of seasonal allergic or perennial allergic rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Mometasone Furoate Nasal Spray may be initiated up to four weeks prior to the anticipated start of the pollen season.
Side Effect
Treatment-related adverse events reported in clinical studies for allergic rhinitis in adult and adolescent patients are shown below (Table 1).
| Table I Allergic Rhinitis-Treatment Related Undesirable Effects for Mometasone Furoate Nasal Spray
Very common (>1/10), common (> 1 /100, < 1/10); uncommon (>1/1000, < 1/100); rare (> I/10,000, < 1/1000); very rare (<1/10,000)
| |
| Respiratory, thoracic and mediastinal disorders
Common: | Epistaxis, Pharyngitis, nasal burning, nasal irritation, nasal ulceration |
| General disorders and administration site conditions
Common: | Headache |
Epistaxis was generally self-limiting and mild in severity and occurred at a higher incidence compared to placebo (5%), but at a comparable or lower incidence when compared to the active control nasal corticosteroids studied (up to 15%). The incidence of all other effects was comparable with that of placebo.
In the pediatric population, the incidence of adverse events, e.g., epistaxis (6%), headache (3%), nasal irritation (2%) and sneezing (2%) was comparable to placebo.
In patients treated for nasal polyposis, the overall incidence of adverse events was comparable to placebo and similar to that observed for patients with allergic rhinitis.
Treatment-related adverse events reported in ≥1% of patients in clinical studies for polyposis are shown below (Table 2)
| Table 2: Polyposis-Treatment Related Undesirable Effects = 1% for Mometasone Furoate Nasal Spray
Very common (>1/10), common (> 1 /100, < 1/10); uncommon (>1/1000, < 1/100); rare (> 1/10,000, < 1/1000); very rare (<1/10,000)
| ||
| 200 mcg once a day | 200 mcg twice a day | |
| Respiratory, thoracic and mediastinal disorders
Upper respiratory tract infection Epistaxis
|
Common Common |
Uncommon Very common |
| Gastrointestinal disorders
Throat irritation |
—– |
Common |
| General disorders and administration site conditions
Headache |
Common |
Common |
In patients treated for acute rhinosinusitis, the incidence of epistaxis for Mometasone Furoate was 3.3% vs. 2.6% for placebo and similar to that observed for patients treated with allergic rhinitis.
Rarely. immediate hypersensitivity reactions, including bronchospasm and dyspnea may occur after intranasal administration of Mometasone Furoate Monohydrate. Very rarely, anaphylaxis and angioedema have been reported.
Disturbances of taste and smell have been reported very rarely.
As with other intranasal corticosteroids rare cases of nasal septum perforation have been reported.
Systemic effects of nasal corticosteroids may occur, particularly when prescribed at high doses for prolonged periods.
Rare cases of glaucoma, increased intraocular pressure and/or cataracts have been reported with the use of intranasal corticosteroids
Ltriz ODS
Ltriz ODS
Each orally disintegrating strip contains:
Levocetirizine Dihydrochloride 5 mg
Excipients q.s.
Uses
Levocetirizine is indicated for:
– the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis;
– the relief of symptoms of chronic idiopathic urticaria.
Side Effect
Somnolence, Dizziness, Headache, Pharyngitis, Rhinitis, Abdominal pain, Dry mouth, nausea, Fatigue. Uncommon: Agitation, Paraesthesia, Diarrhoea, Pruritus, Rash, Asthenia, Malaise.
Azeflumark Nasal Spray
Azeflumark Nasal Spray
Each Metered Spray Delivers:
Azelastine Hydrochloride BP 140 mcg
Fluticasone Propionate BP 50 mcg
Composition:
Azelastine Hydrochloride BP 0.14% w/v
Fluticasone Propionate BP 0.05% w/v
Preservatives: Benzalkonium Chloride Solution BP 0.02% w/v
Phenylethyl Alcohol USP 0.25% w/v
Excipients q.s
Uses
Azeflumark nasal spray is indicated for the management of symptoms of allergic rhinitis, once the need for an antihistamine and corticosteroid has
been established. It is recommended for the treatment of moderate to severe persistent symptoms in adults and adolescents above 12 years of age. It can be used for treating non- allergic vasomotor rhinitis in adults and adolescents, 12 years of age and older. For children aged 5-12 years, recommended for severe symptoms of allergic rhinitis.
Side Effect
The most likely side effects with the combination of azelastine hydrochloride and fluticasone propionate are headache, somnolence, pharyngitis, epistaxis, nasal burning/ irritation, nausea, vomiting, cough, and taste disturbances. The combination may produce a bitter taste which may lead to occasional nausea. This hitter taste usually disappears after sometime.
Metomark Nasal Spray
Metomark Nasal Spray
Each Metered Spray Delivers:
Mometasone Furoate Monohydrate
Equivalent to Mometasone Furoate USP 50 mcg
Composition:
Mometasone Furoate Monohydrate
Equivalent to Mometasone Furoate USP 0.05% w/v
Preservative
Benzalkonium Chloride Solution BP 0.02% w/v
Phenyl Ethyl Alcohol USP 0.25% w/v
Uses
Mometasone Furoate Nasal Spray is indicated for use in adults and children 12 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis.
Mometasone Furoate Nasal Spray is indicated for the treatment of nasal polyps in adults 18 years of age and older.
Mometasone Furoate Nasal Spray is also indicated or use in children 6 to 11 years of age to treat the symptoms of seasonal allergic or perennial allergic rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Mometasone Furoate Nasal Spray may be initiated up to four weeks prior to the anticipated start of the pollen season.
Side Effect
Treatment-related adverse events reported in clinical studies for allergic rhinitis in adult and adolescent patients are shown below (Table 1).
| Table I Allergic Rhinitis-Treatment Related Undesirable Effects for Mometasone Furoate Nasal Spray
Very common (>1/10), common (> 1 /100, < 1/10); uncommon (>1/1000, < 1/100); rare (> I/10,000, < 1/1000); very rare (<1/10,000)
| |
| Respiratory, thoracic and mediastinal disorders
Common: | Epistaxis, Pharyngitis, nasal burning, nasal irritation, nasal ulceration |
| General disorders and administration site conditions
Common: | Headache |
Epistaxis was generally self-limiting and mild in severity and occurred at a higher incidence compared to placebo (5%), but at a comparable or lower incidence when compared to the active control nasal corticosteroids studied (up to 15%). The incidence of all other effects was comparable with that of placebo.
In the pediatric population, the incidence of adverse events, e.g., epistaxis (6%), headache (3%), nasal irritation (2%) and sneezing (2%) was comparable to placebo.
In patients treated for nasal polyposis, the overall incidence of adverse events was comparable to placebo and similar to that observed for patients with allergic rhinitis.
Treatment-related adverse events reported in ≥1% of patients in clinical studies for polyposis are shown below (Table 2)
| Table 2: Polyposis-Treatment Related Undesirable Effects = 1% for Mometasone Furoate Nasal Spray
Very common (>1/10), common (> 1 /100, < 1/10); uncommon (>1/1000, < 1/100); rare (> 1/10,000, < 1/1000); very rare (<1/10,000)
| ||
| 200 mcg once a day | 200 mcg twice a day | |
| Respiratory, thoracic and mediastinal disorders
Upper respiratory tract infection Epistaxis
|
Common Common |
Uncommon Very common |
| Gastrointestinal disorders
Throat irritation |
—– |
Common |
| General disorders and administration site conditions
Headache |
Common |
Common |
In patients treated for acute rhinosinusitis, the incidence of epistaxis for Mometasone Furoate was 3.3% vs. 2.6% for placebo and similar to that observed for patients treated with allergic rhinitis.
Rarely. immediate hypersensitivity reactions, including bronchospasm and dyspnea may occur after intranasal administration of Mometasone Furoate Monohydrate. Very rarely, anaphylaxis and angioedema have been reported.
Disturbances of taste and smell have been reported very rarely.
As with other intranasal corticosteroids rare cases of nasal septum perforation have been reported.
Systemic effects of nasal corticosteroids may occur, particularly when prescribed at high doses for prolonged periods.
Rare cases of glaucoma, increased intraocular pressure and/or cataracts have been reported with the use of intranasal corticosteroids
Ltriz ODS
Ltriz ODS
Each orally disintegrating strip contains:
Levocetirizine Dihydrochloride 5 mg
Excipients q.s.
Uses
Levocetirizine is indicated for:
– the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis;
– the relief of symptoms of chronic idiopathic urticaria.
Side Effect
Somnolence, Dizziness, Headache, Pharyngitis, Rhinitis, Abdominal pain, Dry mouth, nausea, Fatigue. Uncommon: Agitation, Paraesthesia, Diarrhoea, Pruritus, Rash, Asthenia, Malaise.
Derise 25 mcg Inj
Derise
Composition
Darbepoetin alfa is available in 25, 40 mcg dose strengths. 25mcg/0.42 ml, 40mcg/0.40ml
Detailed composition of each strength is as under:
| S. No | Ingredient | 25mcg/0.42 ml
| 40mcg/0.40ml |
| 1 | Darbepoetin alfa (r-DNA origin) | 25 mcg | 40 mcg |
| 2 | Sodium Phosphate Monobasic Monohydrate USP | 0.89 mg | 0.85 mg |
| 3 | odium Phosphate Dibasic Anhydrous USP | 0.28 mg | 0.26 mg |
| 4 | Sodium Chloride USP | 3.44 mg | 3.27 mg |
| 5 | Polysorbate 80 USP | 0.021 mg | 0.020 mg |
| 6 | Water for Injection USP/EP | q.s. to 0.42 mL | q.s. to 0.40 mL |
Uses
Darbepoetin alfa injection is indicated for the treatment of
- Anemia with Chronic Renal Failure including patients on dialysis and patients not on dialysis
- Treatment of symptomatic anemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Side Effect
Chronic Renal Failure Patients
Adult Patients
Adverse reactions occurring in patients treated with Darbepoetin alfa are: Hypertension, dyspnea, peripheral edema, cough, procedural hypotension, angina pectoris, vascular access complications, Fluid overload, rash/erythema and arteriovenous graft thrombosis
Pediatric Patients
The most frequently reported serious adverse reactions with Darbepoetin alfa in clinical trials were hypertension and convulsions. The most commonly reported adverse reactions were hypertension, injection site pain, rash, and convulsions. Studies have not evaluated the effects of Darbepoetin alfa when administered to pediatric patients as the initial treatment for the anemia associated with CKD.
Cancer Patients Receiving Chemotherapy
The adverse reactions from controlled clinical studies and post-marketing experience are hypersensitivity, convulsions, hypertension, thromboembolic events, including pulmonary embolism, myocardial infarction, cerebrovascular disorders encompasses CNS hemorrhages and cerebrovascular accidents (ischemic and hemorrhagic), rash/erythema, Oedema and injection site pain.
Derise 40 mcg Inj
Derise
Composition
Darbepoetin alfa is available in 25, 40 mcg dose strengths. 25mcg/0.42 ml, 40mcg/0.40ml
Detailed composition of each strength is as under:
| S. No | Ingredient | 25mcg/0.42 ml
| 40mcg/0.40ml |
| 1 | Darbepoetin alfa (r-DNA origin) | 25 mcg | 40 mcg |
| 2 | Sodium Phosphate Monobasic Monohydrate USP | 0.89 mg | 0.85 mg |
| 3 | odium Phosphate Dibasic Anhydrous USP | 0.28 mg | 0.26 mg |
| 4 | Sodium Chloride USP | 3.44 mg | 3.27 mg |
| 5 | Polysorbate 80 USP | 0.021 mg | 0.020 mg |
| 6 | Water for Injection USP/EP | q.s. to 0.42 mL | q.s. to 0.40 mL |
Uses
Darbepoetin alfa injection is indicated for the treatment of
- Anemia with Chronic Renal Failure including patients on dialysis and patients not on dialysis
- Treatment of symptomatic anemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Side Effect
Chronic Renal Failure Patients
Adult Patients
Adverse reactions occurring in patients treated with Darbepoetin alfa are: Hypertension, dyspnea, peripheral edema, cough, procedural hypotension, angina pectoris, vascular access complications, Fluid overload, rash/erythema and arteriovenous graft thrombosis
Pediatric Patients
The most frequently reported serious adverse reactions with Darbepoetin alfa in clinical trials were hypertension and convulsions. The most commonly reported adverse reactions were hypertension, injection site pain, rash, and convulsions. Studies have not evaluated the effects of Darbepoetin alfa when administered to pediatric patients as the initial treatment for the anemia associated with CKD.
Cancer Patients Receiving Chemotherapy
The adverse reactions from controlled clinical studies and post-marketing experience are hypersensitivity, convulsions, hypertension, thromboembolic events, including pulmonary embolism, myocardial infarction, cerebrovascular disorders encompasses CNS hemorrhages and cerebrovascular accidents (ischemic and hemorrhagic), rash/erythema, Oedema and injection site pain.
Eritrogen 2000 IU Inj
Eritrogen
Eritrogen 4000 IU Inj
Eritrogen
Derise 25 mcg Inj
Derise
Composition
Darbepoetin alfa is available in 25, 40 mcg dose strengths. 25mcg/0.42 ml, 40mcg/0.40ml
Detailed composition of each strength is as under:
| S. No | Ingredient | 25mcg/0.42 ml
| 40mcg/0.40ml |
| 1 | Darbepoetin alfa (r-DNA origin) | 25 mcg | 40 mcg |
| 2 | Sodium Phosphate Monobasic Monohydrate USP | 0.89 mg | 0.85 mg |
| 3 | odium Phosphate Dibasic Anhydrous USP | 0.28 mg | 0.26 mg |
| 4 | Sodium Chloride USP | 3.44 mg | 3.27 mg |
| 5 | Polysorbate 80 USP | 0.021 mg | 0.020 mg |
| 6 | Water for Injection USP/EP | q.s. to 0.42 mL | q.s. to 0.40 mL |
Uses
Darbepoetin alfa injection is indicated for the treatment of
- Anemia with Chronic Renal Failure including patients on dialysis and patients not on dialysis
- Treatment of symptomatic anemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Side Effect
Chronic Renal Failure Patients
Adult Patients
Adverse reactions occurring in patients treated with Darbepoetin alfa are: Hypertension, dyspnea, peripheral edema, cough, procedural hypotension, angina pectoris, vascular access complications, Fluid overload, rash/erythema and arteriovenous graft thrombosis
Pediatric Patients
The most frequently reported serious adverse reactions with Darbepoetin alfa in clinical trials were hypertension and convulsions. The most commonly reported adverse reactions were hypertension, injection site pain, rash, and convulsions. Studies have not evaluated the effects of Darbepoetin alfa when administered to pediatric patients as the initial treatment for the anemia associated with CKD.
Cancer Patients Receiving Chemotherapy
The adverse reactions from controlled clinical studies and post-marketing experience are hypersensitivity, convulsions, hypertension, thromboembolic events, including pulmonary embolism, myocardial infarction, cerebrovascular disorders encompasses CNS hemorrhages and cerebrovascular accidents (ischemic and hemorrhagic), rash/erythema, Oedema and injection site pain.
Derise 40 mcg Inj
Derise
Composition
Darbepoetin alfa is available in 25, 40 mcg dose strengths. 25mcg/0.42 ml, 40mcg/0.40ml
Detailed composition of each strength is as under:
| S. No | Ingredient | 25mcg/0.42 ml
| 40mcg/0.40ml |
| 1 | Darbepoetin alfa (r-DNA origin) | 25 mcg | 40 mcg |
| 2 | Sodium Phosphate Monobasic Monohydrate USP | 0.89 mg | 0.85 mg |
| 3 | odium Phosphate Dibasic Anhydrous USP | 0.28 mg | 0.26 mg |
| 4 | Sodium Chloride USP | 3.44 mg | 3.27 mg |
| 5 | Polysorbate 80 USP | 0.021 mg | 0.020 mg |
| 6 | Water for Injection USP/EP | q.s. to 0.42 mL | q.s. to 0.40 mL |
Uses
Darbepoetin alfa injection is indicated for the treatment of
- Anemia with Chronic Renal Failure including patients on dialysis and patients not on dialysis
- Treatment of symptomatic anemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
Side Effect
Chronic Renal Failure Patients
Adult Patients
Adverse reactions occurring in patients treated with Darbepoetin alfa are: Hypertension, dyspnea, peripheral edema, cough, procedural hypotension, angina pectoris, vascular access complications, Fluid overload, rash/erythema and arteriovenous graft thrombosis
Pediatric Patients
The most frequently reported serious adverse reactions with Darbepoetin alfa in clinical trials were hypertension and convulsions. The most commonly reported adverse reactions were hypertension, injection site pain, rash, and convulsions. Studies have not evaluated the effects of Darbepoetin alfa when administered to pediatric patients as the initial treatment for the anemia associated with CKD.
Cancer Patients Receiving Chemotherapy
The adverse reactions from controlled clinical studies and post-marketing experience are hypersensitivity, convulsions, hypertension, thromboembolic events, including pulmonary embolism, myocardial infarction, cerebrovascular disorders encompasses CNS hemorrhages and cerebrovascular accidents (ischemic and hemorrhagic), rash/erythema, Oedema and injection site pain.
Eritrogen 2000 IU Inj
Eritrogen
Eritrogen 4000 IU Inj
Eritrogen
Fluritop Mouthwash
Fluoritop Mouthwash
Composition
200ppm (0.04%) of Sodium fluoride
Uses
Anticavity fluoride mouthwash
Hexidine Mouthwash
Hexidine
Composition
Chlorhexidine gluconate 0.2%
Uses
Gold standard Antibacterial antiplaque mouthwash
Prevents dental infections, plaque formation, helps to reduce risk of Covid 19 infection
Alcohol free
RA Thermoseal Gel
RA Thermoseal Gel (15&100gm)
Composition
Potassium Nitrate 5% Sodium monoflurophosphate 0.7%
Indications
For dentinal Hypersensitivity
Gel formula has advantage of less foaming which prevents friction while brushing teeth.
RA Thermoseal Paste
RA Thermoseal paste
Composition
Potassium nitrate 5%, Sodium monoflurophosphate 0.7%
Uses
For Rapid relief from sensitivity
95% patients experience no/slight pain starting from Day 1 of use
Thermoseal Repair
Thermoseal Repair Paste (15&100gm)
Composition
Strontium chloride hexahydrate 10%
Uses
For repair and maintenance of teeth
Prevents wear and tear of teeth
Kids Bunny Gel
Kids bunny dental gel
Composition
Sodium monoflurophosphate 0.3%
Uses
Anticavity toothpaste for Kids
Available in delicious strawberry mint flavor which encourages children to brush teeth
Kids Dyny Brush
Kids Dyny Brush
Tooth brush for children
Uses
Small amd soft bristles which ensure complete cleaning of oral cavity of children without any injuries
Attractive dinosaur handle helps children to like this brush
Thermoseal Tooth Brush
Thermoseal Tooth Brush
Uses
Toothbrush for regular use which ensures complete cleaning of Oral cavity
Thermoseal Smart Tooth Brush
Thermoseal smart brush
Uses
Toothbrush with tongue cleaner at back
Contoured rubber grip makes it easier to handle and use
Rounded head ensures complete cleaning of oral cavity
Thermoseal Ultrasoft
Thermoseal Ultrasoft
Uses
Has very soft bristles which makes it a superior option for patients having dentinal Hypersensitivity, bleeding gums etc
Thermoseal Ortho Brush
Thermoseal Ortho Brush
Uses
Professionally designed brush with long outer bristles and short inner bristles which ensure complete cleaning of and around Orthodontic implants
Clinsodent Brush
Clinsodent toothbrush
Uses
For cleaning of dentures in old people
Thermoseal Proxa NS
Thermoseal Proxa NS
Uses
For effective cleaning of Inter-dental spaces
Younifloss
Younifloss
Uses
Floss for cleaning interdental spaces
Handy and convenient to use and carry
Thermoseal Floss
Thermoseal Floss 50 mtr
50 mtr floss for effective cleaning of Inter-dental spaces
Uses
Floss has unique advantage of thickening on coming in contact with Saliva
Mint flavoured
Wassup ( Mint )
Wassup spray
Uses
Mint flavoured oral spray to fight bad breath
Shine N Smile
Shine N smile
Uses
Tooth polish for whitening the teeth
Orofresh Toothpaste (For Extra Freshness)
Orofresh extra fresh toothpaste
Composition
Sodium monoflurophosphate 0.7%
Uses
Helps in preventing dental caries, decay and refreshing mint flavor helps to fight bad breath
Orofresh Toothpaste (For Sensitivity)
Orofresh Toothpaste (For Sensitivity)
Composition
Potassium nitrate 5%, Sodium monoflurophosphate 0.7%
Uses
For Rapid relief from sensitivity
95% patients experience no/slight pain starting from Day 1 of use
Orofresh Toothpaste (For Kids)
Orofresh Toothpaste (For Kids)
Composition
Sodium monoflurophosphate 0.3%
Uses
Helps to fight cavities, caries and decay in children aged 2yrs and above
Delicious Strawberry flavour encourages children to like the taste and aroma of toothpaste as well as helps fight bad breath
Orofresh Mouthwash
Orofresh
Composition
Chlorhexidine gluconate 0.2%, Zinc 5%, Sodium Fluoride
Uses
Antibacterial, anticavity, antiplaque mouthwash with Zinc Prevents dental infections, plaque formation, helps to reduce risk of Covid 19 infection
Refreshing green tea flavour
Fluritop Mouthwash
Fluoritop Mouthwash
Composition
200ppm (0.04%) of Sodium fluoride
Uses
Anticavity fluoride mouthwash
Hexidine Mouthwash
Hexidine
Composition
Chlorhexidine gluconate 0.2%
Uses
Gold standard Antibacterial antiplaque mouthwash
Prevents dental infections, plaque formation, helps to reduce risk of Covid 19 infection
Alcohol free
RA Thermoseal Gel
RA Thermoseal Gel (15&100gm)
Composition
Potassium Nitrate 5% Sodium monoflurophosphate 0.7%
Indications
For dentinal Hypersensitivity
Gel formula has advantage of less foaming which prevents friction while brushing teeth.
RA Thermoseal Paste
RA Thermoseal paste
Composition
Potassium nitrate 5%, Sodium monoflurophosphate 0.7%
Uses
For Rapid relief from sensitivity
95% patients experience no/slight pain starting from Day 1 of use
Thermoseal Repair
Thermoseal Repair Paste (15&100gm)
Composition
Strontium chloride hexahydrate 10%
Uses
For repair and maintenance of teeth
Prevents wear and tear of teeth
Kids Bunny Gel
Kids bunny dental gel
Composition
Sodium monoflurophosphate 0.3%
Uses
Anticavity toothpaste for Kids
Available in delicious strawberry mint flavor which encourages children to brush teeth
Kids Dyny Brush
Kids Dyny Brush
Tooth brush for children
Uses
Small amd soft bristles which ensure complete cleaning of oral cavity of children without any injuries
Attractive dinosaur handle helps children to like this brush
Thermoseal Tooth Brush
Thermoseal Tooth Brush
Uses
Toothbrush for regular use which ensures complete cleaning of Oral cavity
Thermoseal Smart Tooth Brush
Thermoseal smart brush
Uses
Toothbrush with tongue cleaner at back
Contoured rubber grip makes it easier to handle and use
Rounded head ensures complete cleaning of oral cavity
Thermoseal Ultrasoft
Thermoseal Ultrasoft
Uses
Has very soft bristles which makes it a superior option for patients having dentinal Hypersensitivity, bleeding gums etc
Thermoseal Ortho Brush
Thermoseal Ortho Brush
Uses
Professionally designed brush with long outer bristles and short inner bristles which ensure complete cleaning of and around Orthodontic implants
Clinsodent Brush
Clinsodent toothbrush
Uses
For cleaning of dentures in old people
Thermoseal Proxa NS
Thermoseal Proxa NS
Uses
For effective cleaning of Inter-dental spaces
Younifloss
Younifloss
Uses
Floss for cleaning interdental spaces
Handy and convenient to use and carry
Thermoseal Floss
Thermoseal Floss 50 mtr
50 mtr floss for effective cleaning of Inter-dental spaces
Uses
Floss has unique advantage of thickening on coming in contact with Saliva
Mint flavoured
Wassup ( Mint )
Wassup spray
Uses
Mint flavoured oral spray to fight bad breath
Shine N Smile
Shine N smile
Uses
Tooth polish for whitening the teeth
Orofresh Toothpaste (For Extra Freshness)
Orofresh extra fresh toothpaste
Composition
Sodium monoflurophosphate 0.7%
Uses
Helps in preventing dental caries, decay and refreshing mint flavor helps to fight bad breath
Orofresh Toothpaste (For Sensitivity)
Orofresh Toothpaste (For Sensitivity)
Composition
Potassium nitrate 5%, Sodium monoflurophosphate 0.7%
Uses
For Rapid relief from sensitivity
95% patients experience no/slight pain starting from Day 1 of use
Orofresh Toothpaste (For Kids)
Orofresh Toothpaste (For Kids)
Composition
Sodium monoflurophosphate 0.3%
Uses
Helps to fight cavities, caries and decay in children aged 2yrs and above
Delicious Strawberry flavour encourages children to like the taste and aroma of toothpaste as well as helps fight bad breath
Orofresh Mouthwash
Orofresh
Composition
Chlorhexidine gluconate 0.2%, Zinc 5%, Sodium Fluoride
Uses
Antibacterial, anticavity, antiplaque mouthwash with Zinc Prevents dental infections, plaque formation, helps to reduce risk of Covid 19 infection
Refreshing green tea flavour
Markvir Cream 15 gm
Clobmarksans Cream 10 gm
Clobetamark Cream 15 gm
Quench Cream
Vorif 200 mg
Virq 250 mg
Icon 100 mg
Acylex 200 mg
Acylex 400 mg
Gro-Hair
Markvir Cream 15 gm
Clobmarksans Cream 10 gm
Clobetamark Cream 15 gm
Quench Cream
Vorif 200 mg
Virq 250 mg
Icon 100 mg
Acylex 200 mg
Acylex 400 mg
Gro-Hair
